Oragenics reports test marketing of Probiora3 chewable tablets

The chewable tablets help to whiten teeth and improve breath though the use of a unique combination of safe, naturally occurring bacteria that are released in the mouth by chewing on a mint-flavored tablet that the company has designed to be used twice daily.

The company believes that further analysis and possible further testing of the product will show that Probiora3 will also improve oral health for those millions of people who suffer from chronic tooth and gum problems, although no such representations can be made at this time. The company expects to begin direct-to-consumer sales within the next month through a subsidiary company and to bring the product to the public’s attention through the media.

Jeffrey Hillman, Oragenics’s chief scientific officer, said: “Probiora3 is a blend of three naturally occurring and beneficial oral bacteria. The chewable tablet is the first of our planned products for diagnosing and treating a number of infectious diseases including those that affect the mouth.”